295 related articles for article (PubMed ID: 29922910)
21. Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: a review.
Reynolds MF; Sisk EC; Rasgon NL
Curr Med Chem; 2007; 14(26):2799-812. PubMed ID: 18045126
[TBL] [Abstract][Full Text] [Related]
22. A survey of antiepileptic prescribing to women of childbearing potential in psychiatry.
Wieck A; Rao S; Sein K; Haddad PM
Arch Womens Ment Health; 2007; 10(2):83-5. PubMed ID: 17380253
[TBL] [Abstract][Full Text] [Related]
23. Trends in antiseizure medications utilization among women of childbearing age with epilepsy in Poland between 2015 and 2019.
Wójcik K; Franciszek Kołek M; Dec-Ćwiek M; Słowik A; Bosak M
Epilepsy Behav; 2023 Feb; 139():109091. PubMed ID: 36682232
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of risk minimisation measures for valproate: a drug utilisation study in Europe, analysis of data from Spain.
Ehlken B; Stevanovic I; Kaplan S; Dresco I; Granados D; Toussi M
Rev Neurol; 2021 Dec; 73(11):373-382. PubMed ID: 34826330
[TBL] [Abstract][Full Text] [Related]
25. Valproate in the treatment of epilepsy in girls and women of childbearing potential.
Tomson T; Marson A; Boon P; Canevini MP; Covanis A; Gaily E; Kälviäinen R; Trinka E
Epilepsia; 2015 Jul; 56(7):1006-19. PubMed ID: 25851171
[TBL] [Abstract][Full Text] [Related]
26. Real-world prescribing trends of valproate in women with epilepsy in Korea.
Han SH; Lee H; Shin JY; Moon HJ; Lee SY
Epilepsy Behav; 2021 Feb; 115():107700. PubMed ID: 33421853
[TBL] [Abstract][Full Text] [Related]
27. Polycystic ovary syndrome in women using valproate: a review.
Bilo L; Meo R
Gynecol Endocrinol; 2008 Oct; 24(10):562-70. PubMed ID: 19012099
[TBL] [Abstract][Full Text] [Related]
28. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
[TBL] [Abstract][Full Text] [Related]
29. Risks of neurobehavioral teratogenicity associated with prenatal exposure to valproate monotherapy: a systematic review with regulatory repercussions.
Gentile S
CNS Spectr; 2014 Aug; 19(4):305-15. PubMed ID: 24571806
[TBL] [Abstract][Full Text] [Related]
30. Valproic Acid in Women and Girls of Childbearing Age.
Gotlib D; Ramaswamy R; Kurlander JE; DeRiggi A; Riba M
Curr Psychiatry Rep; 2017 Sep; 19(9):58. PubMed ID: 28726062
[TBL] [Abstract][Full Text] [Related]
31. Valproate risk form-Surveying 215 clinicians involving 4775 encounters.
Angus-Leppan H; Moghim MM; Cock H; Kinton L; Synnott Wells M; Shankar R
Acta Neurol Scand; 2020 Jun; 141(6):483-490. PubMed ID: 32072612
[TBL] [Abstract][Full Text] [Related]
32. [Anticonvulsants in the treatment of bipolar disorder].
Grunze H
Neuropsychiatr; 2007; 21(2):110-20. PubMed ID: 17640497
[TBL] [Abstract][Full Text] [Related]
33. Utilization of Antiepileptic Medicines in Swedish Children and Adolescents with Different Diagnoses.
Karlsson Lind L; Wide K; Wettermark B; von Euler M
Basic Clin Pharmacol Toxicol; 2018 Jul; 123(1):94-100. PubMed ID: 29427409
[TBL] [Abstract][Full Text] [Related]
34. Valproate and female patients: Prescribing attitudes of Italian epileptologists.
Giuliano L; La Neve A; Galimberti CA; Aguglia U; Bilo L; Ermio C; Monti G; Zambrelli E; Zenesini C; Mostacci B
Epilepsy Behav; 2019 Aug; 97():182-186. PubMed ID: 31252276
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of risk minimization measures for valproate: a drug utilization study based on implementation of a risk minimization programme in Europe, analysis of data from the UK.
Ehlken B; Nishikawa C; Kaplan S; Dresco I; Granados D; Toussi M
Curr Med Res Opin; 2022 Mar; 38(3):461-468. PubMed ID: 34931552
[TBL] [Abstract][Full Text] [Related]
36. Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009.
Hayes J; Prah P; Nazareth I; King M; Walters K; Petersen I; Osborn D
PLoS One; 2011; 6(12):e28725. PubMed ID: 22163329
[TBL] [Abstract][Full Text] [Related]
37. The use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004-2007 - a prescription database study.
Bramness JG; Grøholt B; Engeland A; Furu K
J Affect Disord; 2009 Oct; 117(3):208-11. PubMed ID: 19189871
[TBL] [Abstract][Full Text] [Related]
38. Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature.
Nasrallah HA; Ketter TA; Kalali AH
J Affect Disord; 2006 Oct; 95(1-3):69-78. PubMed ID: 16780960
[TBL] [Abstract][Full Text] [Related]
39. Valproate in Pregnancy: Recent Research and Regulatory Responses.
Andrade C
J Clin Psychiatry; 2018; 79(3):. PubMed ID: 29873961
[TBL] [Abstract][Full Text] [Related]
40. Use of Valproate in Women: An Audit of Prescriptions to 10,001 Psychiatry, Neurology, and Neurosurgery Outpatients.
Andrade C; Jyothi SA; Renitha T; Anuroopa KP; Dona B; Basila T; Nimmy G
J Clin Psychiatry; 2021 Nov; 83(1):. PubMed ID: 34813688
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
